690 — Uni-Bio Science Cashflow Statement
0.000.00%
- HK$668.78m
- HK$614.07m
- HK$552.98m
- 59
- 61
- 59
- 66
Annual cashflow statement for Uni-Bio Science, fiscal year end - December 31st, HKD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | HKAS | HKAS | HKAS | HKAS | HKAS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -70.9 | -20 | 43.3 | 75.9 | 91.2 |
Depreciation | |||||
Amortisation | |||||
Non-Cash Items | 44.9 | 18.6 | 2.75 | 5.92 | 14.1 |
Unusual Items | |||||
Equity in Net Earnings/Losses | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -10.4 | -7.42 | -14.9 | 0.145 | -59.9 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Payable / Accrued Expenses | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | -15.5 | 12 | 48.7 | 98.8 | 66.7 |
Capital Expenditures | -13 | -8.43 | -28.4 | -59.7 | -38 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | -11.7 | 50.6 | 1.4 | -16.4 | -130 |
Sale of Business | |||||
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -24.6 | 42.1 | -27 | -76.1 | -168 |
Financing Cash Flow Items | -0.073 | 7.17 | -5.22 | 2.83 | -2.77 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -5.41 | 0.478 | 2.58 | 24.5 | 27.8 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -41.2 | 58.6 | 14.6 | 31 | -64.2 |